BARDA

ASPR And BARDA Move To Close The Nitrile Glove Gap The Biomedical Advanced Research and Development Authority (BARDA), through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP‑Consortium), has released a new Request for Project Proposals (RPP 26‑09‑Gloves) focused on Expansion of Domestic Manufacturing Capacity for Nitrile Gloves. ASPR’s Center for Industrial Base Management and Supply Chain (IBMSC)

The Biomedical Advanced Research and Development Authority (BARDA), working through the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP‑Consortium), has released a new Request for Project Proposals (RPP 26‑04‑NBR) focused on Sustainment of PPE Capacities – Nitrile Butadiene Rubber (NBR). ASPR’s Industrial Base Management and Supply Chain (IBMSC) is seeking projects that will sustain and strengthen domestic NBR

The Biomedical Advanced Research and Development Authority (BARDA) has issued a Sources Sought Notice titled “Advanced Dermal Regeneration Substitutes for Treatment of Severe Burns and Complex Traumatic Injuries” (BARDA-CBRN-07282026) to identify commercially available or near commercial technologies that address large-area skin loss from burns and traumatic injuries in a mass casualty setting. This notice is for

Overview of the Opportunity The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Information (RFI) titled “Biosafety Level 4 Preclinical and Nonclinical Support for Medical Countermeasure Development (BSL4)”. Issued July 9, 2026, the RFI is a market research exercise to map out who can deliver preclinical and nonclinical

Download the Solicitation Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA) is looking at a specific problem: how to repurpose specialized equipment originally designed to manufacture an emergency autoinjector platform into a broader drug delivery solution. Through the Rapid Response Partnership Vehicle (RRPV), BARDA released a new Request for Information (RFI), “Repurposing Equipment

Download the Solicitation Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a Request for Information (RFI) titled “Advanced Clinical Development and Licensure of an Adjuvanted Egg-based Influenza Vaccine.” Through this market research effort, BARDA is seeking feedback from industry, academia, and other stakeholders to

Download the Solicitation Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a Request for Information (RFI) titled “High Performance Antigen Diagnostics.” Through this market research effort, BARDA is seeking feedback from industry, academia, and other stakeholders to better understand the landscape of current and emerging high-performance immunoassay

Download the Solicitation The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has officially released Request for Project Proposals (RPP) RRPV 26-13-BundiVx for the Bundibugyo Virus Outbreak Response Vaccines (BundiVx) Program. The solicitation seeks to accelerate the development of investigational vaccine candidates targeting Bundibugyo ebolavirus (BDBV), the virus responsible for

Download the RFI Overview of the RFI The Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR), has released a Request for Information (RFI) titled “Protection Before Day One Vaccine: Advancing Broadly Protective Seasonal Influenza Vaccines with Pandemic Coverage.” Through this market research effort, BARDA is seeking feedback from industry, academia, and